Abstract

We read with great interest the letter from Heresbach & Pienkowski on the recent French recommendations for post-polypectomy endoscopic surveillance [1] [2]. We agree with the authors that the main differences between the latter and the recent guidelines from the European Society of Gastrointestinal Endoscopy (ESGE) are represented by the surveillance interval for the low-risk group and – to a lesser extent – by the inclusion of patients with villous histology in the high risk group [2] [3].

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.